Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

OncoCyte Corporation (OCX)

  • Event
  • Aug. 01, 2022, 12:05 UTC
  • 13
  • 1 comments

(94% Neutral) Oncocyte Corporation (OCX) Announces Clinical Development Update

Comment Full text

Chimerix Inc (CMRX)

  • Event
  • Aug. 01, 2022, 11:54 UTC
  • 13
  • 1 comments

(70% Positive) Chimerix, Inc. (CMRX) Announces Business Combination

Comment Full text

HUTCHMED DRC (HCM)

  • Event
  • Aug. 01, 2022, 11:33 UTC
  • 9
  • 1 comments

(10% Negative) HUTCHMED DRC (HCM) Reports Q2 2022 Financial Results (Form 6-K)

Comment Full text

ATAI Life Sciences (ATAI)

  • Event
  • Aug. 01, 2022, 11:31 UTC
  • 12
  • 1 comments

(99% Neutral) ATAI LIFE SCIENCES N.V. (ATAI) Announces Business Combination

Comment Full text

ObsEva SA (company was delisted NASDAQ) (OBSV)

  • Event
  • Aug. 01, 2022, 11:21 UTC
  • 9
  • 1 comments

(99% Neutral) ObsEva SA (company was delisted NASDAQ) (OBSV) Announces Clinical Development Update (Form 6-K)

Comment Full text

Tonix Pharmaceuticals Holding Corp (TNXP)

  • Event
  • Aug. 01, 2022, 11:07 UTC
  • 12
  • 1 comments

(99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Clinical Development Update

Comment Full text

TherapeuticsMD Inc (TXMD)

  • Event
  • Aug. 01, 2022, 10:55 UTC
  • 12
  • 1 comments

(35% Negative) TherapeuticsMD, Inc. (TXMD) Announces Business Combination

Comment Full text

HUTCHMED DRC (HCM)

  • Event
  • Aug. 01, 2022, 10:53 UTC
  • 9
  • 1 comments

(99% Neutral) HUTCHMED DRC (HCM) Announces Clinical Development Update (Form 6-K)

Comment Full text

Beam Therapeutics Inc (BEAM)

  • Event
  • Aug. 01, 2022, 10:50 UTC
  • 12
  • 1 comments

(10% Negative) Beam Therapeutics Inc. (BEAM) Announces Clinical Trial Timeline Adjustment

Comment Full text

Cyteir Therapeutics (CYT)

  • Event
  • Aug. 01, 2022, 05:54 UTC
  • 96
  • 0 comments

Cyteir Therapeutics - 2022 Wedbush PacGrow Healthcare Virtual Conference

Comment Full text
  • Previous
  • 144
  • 145
  • 146
  • 147
  • 148
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189155)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124506)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin